Myricx Bio
Developer of precision medicines intended to unlock the potential of N-myristoyl transferase as a therapeutic target. The company offers novel proprietary inhibitors for humans, which result in specif...
Valuation
$0
Share Price
N/A
Total Raised
$121M
Last Round
N/A